Annual ROE
-11.22%
+1.69%+13.09%
31 December 2023
Summary:
XBiotech annual return on equity is currently -11.22%, with the most recent change of +1.69% (+13.09%) on 31 December 2023. During the last 3 years, it has fallen by -9.19% (-452.71%). XBIT annual ROE is now -112.68% below its all-time high of 88.49%, reached on 31 December 2019.XBIT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-15.99%
+0.53%+3.21%
30 September 2024
Summary:
XBiotech quarterly return on equity is currently -15.99%, with the most recent change of +0.53% (+3.21%) on 30 September 2024. Over the past year, it has dropped by -6.03% (-60.54%). XBIT quarterly ROE is now -105.54% below its all-time high of 288.62%, reached on 31 December 2019.XBIT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIT ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +13.1% | -60.5% |
3 y3 years | -452.7% | -317.5% |
5 y5 years | +78.0% | +64.6% |
XBIT ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -452.7% | +13.1% | -317.5% | +3.2% |
5 y | 5 years | -112.7% | +78.0% | -105.5% | +64.6% |
alltime | all time | -112.7% | +94.5% | -105.5% | +87.7% |
XBiotech ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -15.99%(-3.2%) |
June 2024 | - | -16.52%(+18.2%) |
Mar 2024 | - | -13.98%(+29.2%) |
Dec 2023 | -11.22%(-13.1%) | -10.82%(+8.6%) |
Sept 2023 | - | -9.96%(-16.7%) |
June 2023 | - | -11.95%(-6.7%) |
Mar 2023 | - | -12.81%(-0.6%) |
Dec 2022 | -12.91%(+128.9%) | -12.89%(-6.7%) |
Sept 2022 | - | -13.81%(+45.8%) |
June 2022 | - | -9.47%(+41.3%) |
Mar 2022 | - | -6.70%(+22.5%) |
Dec 2021 | -5.64%(+177.8%) | -5.47%(+42.8%) |
Sept 2021 | - | -3.83%(+10.7%) |
June 2021 | - | -3.46%(-12.6%) |
Mar 2021 | - | -3.96%(+51.1%) |
Dec 2020 | -2.03%(-102.3%) | -2.62%(-101.7%) |
Sept 2020 | - | 151.11%(-15.2%) |
June 2020 | - | 178.30%(-18.3%) |
Mar 2020 | - | 218.15%(-24.4%) |
Dec 2019 | 88.49% | 288.62%(-739.2%) |
Sept 2019 | - | -45.15%(-3.9%) |
June 2019 | - | -46.99%(-9.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | -51.87%(+20.4%) |
Dec 2018 | -51.06%(-7.3%) | -43.08%(+4.0%) |
Sept 2018 | - | -41.44%(+4.0%) |
June 2018 | - | -39.84%(-4.0%) |
Mar 2018 | - | -41.51%(-11.5%) |
Dec 2017 | -55.10%(-38.3%) | -46.90%(-21.9%) |
Sept 2017 | - | -60.08%(-11.5%) |
June 2017 | - | -67.91%(-5.4%) |
Mar 2017 | - | -71.77%(+4.8%) |
Dec 2016 | -89.33%(+145.6%) | -68.48%(+24.9%) |
Sept 2016 | - | -54.81%(+16.3%) |
June 2016 | - | -47.14%(+29.6%) |
Mar 2016 | - | -36.37%(-4.0%) |
Dec 2015 | -36.37%(-1.2%) | -37.87%(+4.3%) |
Sept 2015 | - | -36.31%(-17.8%) |
June 2015 | - | -44.18%(-23.8%) |
Mar 2015 | - | -57.97%(+1.7%) |
Dec 2014 | -36.80%(-62.1%) | -56.98%(-56.2%) |
Sept 2014 | - | -130.14%(+22.2%) |
June 2014 | - | -106.53%(+55.9%) |
Mar 2014 | - | -68.34%(+181.0%) |
Dec 2013 | -97.06%(-52.8%) | -24.32% |
Dec 2012 | -205.64% | - |
FAQ
- What is XBiotech annual return on equity?
- What is the all time high annual ROE for XBiotech?
- What is XBiotech annual ROE year-on-year change?
- What is XBiotech quarterly return on equity?
- What is the all time high quarterly ROE for XBiotech?
- What is XBiotech quarterly ROE year-on-year change?
What is XBiotech annual return on equity?
The current annual ROE of XBIT is -11.22%
What is the all time high annual ROE for XBiotech?
XBiotech all-time high annual return on equity is 88.49%
What is XBiotech annual ROE year-on-year change?
Over the past year, XBIT annual return on equity has changed by +1.69% (+13.09%)
What is XBiotech quarterly return on equity?
The current quarterly ROE of XBIT is -15.99%
What is the all time high quarterly ROE for XBiotech?
XBiotech all-time high quarterly return on equity is 288.62%
What is XBiotech quarterly ROE year-on-year change?
Over the past year, XBIT quarterly return on equity has changed by -6.03% (-60.54%)